Morepen Labs zooms 8% on USFDA nod to market anti-allergy drug
16-Dec-2021
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22
16-Dec-2021
Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22
16-Dec-2021
Morepen gets USFDA Approval for Fexofinadine (Allegra)
16-Dec-2021
Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride
16-Dec-2021
Morepen Laboratories receives USFDA approval for Fexofinadin
16-Dec-2021
Morepen gets USFDA nod to market generic anti-allergy drug
16-Dec-2021
Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride
16-Dec-2021
Morepen gets USFDA nod for anti-allergy drug
16-Dec-2021
Morepen Labs anti-allergy drug Fexofinadine gets USFDA approval
16-Dec-2021
Morepen gets USFDA Approval for Fexofinadine
16-Dec-2021
Noticias farmacéuticas: Últimas noticias farmacéuticas, noticias y actualizaciones farmacéuticas indias
16-Dec-2021
Actualités pharmaceutiques : dernières actualités pharmaceutiques, actualités pharmaceutiques indiennes et mises à jour
16-Dec-2021
Morepen Labs’ exports to get ‘major boost’ with FDA nod for Allegra
16-Dec-2021
Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride
16-Dec-2021
Morepen gets USFDA nod for Fexofinadine (Allegra)
16-Dec-2021
Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)
16-Dec-2021
Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22
16-Dec-2021
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22
16-Dec-2021
Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride
16-Dec-2021
Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)
16-Dec-2021
This news turns out to be a lucky charm for Morepen Laboratories; read to find out more!
16-Dec-2021
Morepen gets USFDA nod to market generic anti-allergy drug
16-Dec-2021
Morepen bags US FDA approval for allergy drug Allegra
16-Dec-2021
Morepen gets USFDA nod to market generic anti-allergy drug
16-Dec-2021
Morepen gets USFDA nod to market generic anti-allergy drug Fexofinadine Hydrochloride
16-Dec-2021
Morepen Laboratories receives USFDA approval
16-Dec-2021
Morepen Labs has seen 36% growth in medical devices in Q2, Dr Morepen could be an IPO candidate: Sushil Suri
16-Dec-2021
Morepen Laboratories gets USFDA nod for Fexofinadine
16-Dec-2021
Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride
16-Dec-2021
Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)
15-Dec-2021
Morepen Laboratories gets USFDA nod to market generic anti-allergy drug
15-Dec-2021
Morepen gets USFDA nod to market generic anti-allergy drug
15-Dec-2021
Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22
15-Dec-2021
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22
03-Dec-2021